- Home
- ALTI vs CADL Comparison
ALTI vs CADL Comparison
Compare ALTI & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTI
- CADL
- Stock Information
- Founded
- ALTI 2020
- CADL 1999
- Country
- ALTI United States
- CADL United States
- Employees
- ALTI N/A
- CADL N/A
- Industry
- ALTI Investment Managers
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- ALTI Finance
- CADL Health Care
- Exchange
- ALTI Nasdaq
- CADL Nasdaq
- Market Cap
- ALTI 283.9M
- CADL 306.4M
- IPO Year
- ALTI N/A
- CADL 2021
- Fundamental
- Price
- ALTI $2.85
- CADL $8.06
- Analyst Decision
- ALTI
- CADL Strong Buy
- Analyst Count
- ALTI 0
- CADL 4
- Target Price
- ALTI N/A
- CADL $21.00
- AVG Volume (30 Days)
- ALTI 127.1K
- CADL 1.2M
- Earning Date
- ALTI 03-13-2025
- CADL 03-13-2025
- Dividend Yield
- ALTI N/A
- CADL N/A
- EPS Growth
- ALTI N/A
- CADL N/A
- EPS
- ALTI N/A
- CADL N/A
- Revenue
- ALTI $206,935,000.00
- CADL N/A
- Revenue This Year
- ALTI $25.79
- CADL N/A
- Revenue Next Year
- ALTI $9.88
- CADL N/A
- P/E Ratio
- ALTI N/A
- CADL N/A
- Revenue Growth
- ALTI N/A
- CADL N/A
- 52 Week Low
- ALTI $2.33
- CADL $1.40
- 52 Week High
- ALTI $6.36
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- ALTI 36.47
- CADL 45.77
- Support Level
- ALTI $2.33
- CADL $8.33
- Resistance Level
- ALTI $3.14
- CADL $9.08
- Average True Range (ATR)
- ALTI 0.33
- CADL 0.59
- MACD
- ALTI -0.02
- CADL -0.04
- Stochastic Oscillator
- ALTI 39.69
- CADL 42.70
About ALTI AlTi Global Inc.
AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments that includes Wealth Management and Strategic Alternatives. Wealth Management includes providing holistic solutions for their wealth management clients through their comprehensive range of wealth management services, including investment management and advisory services. Strategic Alternatives segment, it assists their investors with alternative investments and co-investments by providing access to highly differentiated opportunities in these areas.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.